Pharmaceutical Business Investment Opportunities

Located in Si Racha, the business specializes in recreational cannabis sales through an extensive retail network of 20 to 30 shops, all developed in-house by a team of promoters with over 8 years of industry experience. - Established in November last year, the business generated consistent monthly revenues of USD 10,000 to 15,000, particularly thriving during the high tourist season until operations were temporarily paused in May. - The pause is to facilitate the acquisition of key certifications, including GMP, in preparation for expansion into the medical cannabis sector, specifically the production and commercialization of Rick Simpson Oil (RSO) in capsule form for cancer treatment. - Clinical trials for the medical product have been successfully conducted, and the company is ready to resume operations by December with a diversified portfolio. - All cannabis products, including recreational items such as packets, joints, and packaged flowers, are cultivated, dried, cured, and processed entirely in-house, ensuring consistent quality and supply chain control. - Planning to develop a dedicated website to support e-commerce and build brand presence, while the company actively explores medical tourism opportunities and export potential in markets such as Australia, Germany, and Russia. - The business holds a valid operating license and trademark registration, positioning it to scale its offerings while maintaining regulatory compliance and capitalizing on international demand. - The business is registered and operates in Thailand, while the promoter is currently based in Russia and travels between both countries to oversee operations.

Bangkok-based private limited company, established 5 years ago, is a dynamic and forward-thinking scientific distributor focused on distributing lab equipment, chemicals, biotech R&D services, and herbal health products. - The company has primarily been involved in importing and distribution, mainly sourcing products from the USA and China, and is now ready to transition into becoming manufacturer and exporter. - They are proud to be authorized distributors of world-renowned brands such as Sino Biological, FineTest, TargetMol, ELK Biotechnology, Reed Biotech, and BioBase, ensuring clients access to globally recognized products at competitive prices. - The company's mission is to bridge science with innovation by providing high-quality laboratory equipment, biological reagents, and herbal-based health products to research institutions, healthcare providers, universities, and the broader scientific community. - With previous annual sales of approximately THB 2 million and recent monthly sales of THB 429k, the business maintains a strong EBITDA margin of over 40%. - We now seek investment to scale operations by building a new GMP-compliant factory in Suphanburi province, to expand production capabilities and meet the rising global demand for natural and scientific products. - In the next year, operations will expand with a GMP-compliant factory focused on manufacturing herbal medicines, natural extracts, food and cosmetic ingredients, aligning with global quality and safety standards. - For the new GMP factory, we plan to buy land and construct a new facility on 9 rai of land in Suphanburi province. The company plans to start with a small-scale project, allowing for scalability in the future. - The company holds key licenses, including: 1. Food import license. 2. Cosmetic import license. 3. Medical device import license. Most importantly, we hold a Thai Traditional Medicine license, which is essential for establishing and running a Thai herbal factory. - Led by a visionary founder, the company offers strategic, silent, or foreign investment roles, providing opportunities for high returns and international expansion. We are committed to: 1. Supporting scientific research and education. 2. Promoting natural health innovation. 3. Offering outstanding service with local insight and global quality. The company aims to become a trusted partner in advancing science, health, and sustainability, locally and internationally.

Located in Pune, this business specializes in the export and marketing of pharmaceuticals and nutraceuticals, tapping into a growing global health market. - The product range includes oral tablets, capsules, syrups, and specific categories like Cephalosporins and beta-lactams, catering to diverse health needs. - Currently generating annual sales of approximately 6 Crore INR, the company seeks to expand internationally into various countries, leveraging its current approvals in markets like Cambodia, Ethiopia, and the UK. - The company has over 100 products registered abroad, highlighting its global reach and compliance with international standards. - With a solid customer base of over 50 clients, including importers and distributors, the business maintains robust partnerships for efficient market penetration. - The company collaborates with third-party manufacturers across key cities such as Hyderabad, Mumbai, New Delhi, Chandigarh, and Ghaziabad to ensure flexibility and scalability in production. - The business exports to wholesale and large distribution channels in countries such as Myanmar, Sri Lanka, Bangladesh, Ethiopia, Kenya, T&T, Ghana, Mauritius, Botswana, Europe, and others. - We have 8 permanent employees who help us in the smooth operations of our business.

Engaged in pharmaceutical manufacturing, supplying tablets and capsules to both domestic and international markets. - Operates from an 18,000 sq. ft. constructed manufacturing facility located in Gujarat. - The facility supports a monthly production of approximately 4 crore tablets/capsules. - Holds a valid drug license and GST registration, Exim license, ensuring regulatory compliance for manufacturing and distribution. - Business model centers on contract manufacturing and long-term partnerships with pharma companies. - Team includes experienced professionals with technical and regulatory expertise in pharma manufacturing and export compliance.

Based in Pune, this pharmaceutical business specializes in the distribution of multiple antibiotic brands. - The company's top-selling products, Meropenem and Ertapenem, are distributed to traders, hospitals, and pharmacists, showcasing a diverse customer base within the generic pharmaceuticals industry. - The business experiences seasonality in sales but anticipates doubling its revenue during peak seasons over the next few months. - Currently, the company caters to 4 to 5 main customers, highlighting the need for investment to expand its customer base and increase market penetration. - The business plans to establish an antibiotic vial manufacturing unit, targeting a production capacity of 70k vials per day, aiming to become a contract manufacturer for leading pharmaceutical brands. - With a confirmed working order worth INR 4 crore, the company is poised to boost production and considers international export as a strategic growth area, offering significant investment potential. - The business holds a drug license, ensuring compliance with regulatory standards. The FDA license process is currently underway.

Business operates within the pharmaceutical and healthcare industry, focusing primarily on marketing medicines. - Operational for more than a year, the company is supported by a dedicated five-person team, three focused on marketing, one managing finance, and one overseeing overall management. These 5 employees are essential for smooth operations. - The company generates revenue by promoting its pharmaceutical products through doctors who in turn, recommend them to end patients. - With monthly sales ranging between ₹1 lakh and ₹2.5 lakh, it aims to scale its operations by securing investment. - Owners believe in the long-term potential and prefer securing investment to retain control and steer the company towards greater value. - The business has a registration certificate and a drug license. - The business owner is open to negotiating the equity stake based on the terms of investment.